European cost-effectiveness study of uPA/PAI-1 biomarkers to guide adjuvant chemotherapy decisions in breast cancer

Sophie Marguet*, Chafika Mazouni, Bram L. T. Ramaekers, Ariane Dunant, Ronald Kates, Volker R. Jacobs, Manuela A. Joore, Nadia Harbeck, Julia Bonastre

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)168-179
JournalEuropean Journal of Cancer
Volume63
DOIs
Publication statusPublished - Aug 2016

Keywords

  • Breast cancer
  • Adjuvant chemotherapy
  • Cost effectiveness
  • uPA/PAI-1
  • Quality of life

Cite this